Healthcare Triangle, Inc.
HCTI
$0.1446
-$0.0032-2.17%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -68.98% | -68.98% | -65.00% | -58.23% | -37.48% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -68.98% | -68.98% | -65.00% | -58.23% | -37.48% |
| Cost of Revenue | -65.03% | -72.15% | -68.29% | -62.46% | -41.65% |
| Gross Profit | -83.27% | -57.70% | -53.88% | -36.35% | -15.66% |
| SG&A Expenses | -28.71% | -44.38% | -41.81% | -39.24% | -34.20% |
| Depreciation & Amortization | 36.25% | -51.83% | -33.42% | -38.67% | -190.33% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -59.98% | -61.52% | -56.90% | -55.42% | -58.16% |
| Operating Income | -245.19% | 23.43% | 13.61% | 46.77% | 107.20% |
| Income Before Tax | 19.62% | 35.69% | 15.27% | 43.02% | 65.53% |
| Income Tax Expenses | -42.86% | -50.00% | -80.00% | -73.68% | -41.67% |
| Earnings from Continuing Operations | 19.71% | 35.72% | 15.45% | 43.20% | 65.47% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 19.71% | 35.72% | 15.45% | 43.20% | 65.47% |
| EBIT | -245.19% | 23.43% | 13.61% | 46.77% | 107.20% |
| EBITDA | -105.32% | -1.73% | -29.94% | 41.67% | 234.66% |
| EPS Basic | 43.65% | 51.48% | 32.06% | 46.80% | 66.77% |
| Normalized Basic EPS | -2,570.00% | 51.46% | 31.90% | 46.63% | 100.62% |
| EPS Diluted | 43.65% | 51.48% | 32.06% | 46.80% | 66.77% |
| Normalized Diluted EPS | -2,570.00% | 51.46% | 31.90% | 46.63% | 100.62% |
| Average Basic Shares Outstanding | 42.50% | 32.45% | 24.42% | 6.75% | 3.89% |
| Average Diluted Shares Outstanding | 42.50% | 32.45% | 24.42% | 6.75% | 3.89% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |